Public Employees Retirement Association of Colorado Has $1.70 Million Position in The Clorox Company (NYSE:CLX)

Public Employees Retirement Association of Colorado lessened its holdings in The Clorox Company (NYSE:CLX) by 4.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,452 shares of the company’s stock after selling 555 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Clorox were worth $1,699,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Corient Private Wealth LLC lifted its position in shares of Clorox by 7.1% during the 4th quarter. Corient Private Wealth LLC now owns 33,570 shares of the company’s stock worth $4,787,000 after buying an additional 2,230 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Clorox by 1.0% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 48,102 shares of the company’s stock valued at $6,859,000 after purchasing an additional 498 shares in the last quarter. Team Hewins LLC acquired a new stake in shares of Clorox in the 4th quarter valued at $203,000. Orion Portfolio Solutions LLC grew its holdings in shares of Clorox by 40.8% in the 4th quarter. Orion Portfolio Solutions LLC now owns 36,963 shares of the company’s stock worth $5,257,000 after purchasing an additional 10,704 shares during the last quarter. Finally, Advisory Services Network LLC increased its position in shares of Clorox by 39.4% during the 4th quarter. Advisory Services Network LLC now owns 19,507 shares of the company’s stock worth $2,782,000 after purchasing an additional 5,510 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.51% of the stock is owned by insiders.

Clorox Price Performance

Shares of CLX stock opened at $164.84 on Tuesday. The firm’s 50 day moving average price is $149.75 and its two-hundred day moving average price is $143.76. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The stock has a market cap of $20.47 billion, a PE ratio of 85.41, a PEG ratio of 3.29 and a beta of 0.40.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, analysts forecast that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. Clorox’s dividend payout ratio is 252.85%.

Analyst Ratings Changes

CLX has been the topic of several research analyst reports. Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, Barclays upped their price target on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Six analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.